| Product NDC: | 0093-0309 |
| Proprietary Name: | Clemastine Fumarate |
| Non Proprietary Name: | Clemastine Fumarate |
| Active Ingredient(s): | .5 mg/5mL & nbsp; Clemastine Fumarate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-0309 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073399 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950329 |
| Package NDC: | 0093-0309-12 |
| Package Description: | 120 mL in 1 BOTTLE (0093-0309-12) |
| NDC Code | 0093-0309-12 |
| Proprietary Name | Clemastine Fumarate |
| Package Description | 120 mL in 1 BOTTLE (0093-0309-12) |
| Product NDC | 0093-0309 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clemastine Fumarate |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 19950329 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | CLEMASTINE FUMARATE |
| Strength Number | .5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |